Phase I trials of the lysine-specific demethylase 1 inhibitor, GSK2879552, as mono- and combination-therapy in relapsed/refractory acute myeloid leukemia or high-risk myelodysplastic syndromes. Issue 2 (28th January 2022)

Record Type:
Journal Article
Title:
Phase I trials of the lysine-specific demethylase 1 inhibitor, GSK2879552, as mono- and combination-therapy in relapsed/refractory acute myeloid leukemia or high-risk myelodysplastic syndromes. Issue 2 (28th January 2022)
Main Title:
Phase I trials of the lysine-specific demethylase 1 inhibitor, GSK2879552, as mono- and combination-therapy in relapsed/refractory acute myeloid leukemia or high-risk myelodysplastic syndromes
Authors:
Roboz, Gail J.
Yee, Karen
Verma, Amit
Borthakur, Gautam
de la Fuente Burguera, Adolfo
Sanz, Guillermo
Mohammad, Helai P.
Kruger, Ryan G.
Karpinich, Natalie O.
Ferron-Brady, Geraldine
Acusta, Andre
Del Buono, Heather
Collingwood, Therese
Ballas, Marc
Dhar, Arindam
Wei, Andrew H.
Abstract:
Is Part Of:
Leukemia & lymphoma. Volume 63:Issue 2(2022)
Journal:
Leukemia & lymphoma
Issue:
Volume 63:Issue 2(2022)
Issue Display:
Volume 63, Issue 2 (2022)
Year:
2022
Volume:
63
Issue:
2
Issue Sort Value:
2022-0063-0002-0000
Page Start:
463
Page End:
467
Publication Date:
2022-01-28
Subjects:
Leukemia -- Periodicals
Lymphomas -- Periodicals
616.99419
Journal URLs:
http://informahealthcare.com ↗
DOI:
10.1080/10428194.2021.2012667 ↗
Languages:
English
ISSNs:
1042-8194
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 5185.251500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:
20742.xml